News
Leader in the development, production and
commercialisation of pharmacogenetics tests
for cancer precision medicine.
2710, 2015
Agena Bioscience and Diatech Pharmacogenetics Announce Plan to Launch Actionable, Targeted CE-IVD Marked Oncology Assays for Colon, Lung, and Melanoma Treatment
SAN DIEGO, Calif., Oct. 27, 2015 — Agena Bioscience announced [...]
2703, 2015
Diatech Pharmacogenetics obtained by the European Union a founding of Euro 2 million in Horizon 2020
The Group Diatech, leader in Italy of pharmacogenetics and pharmacogenomics [...]
403, 2015
Il Gruppo Diatech partecipa a NGS 2015
From the clinic to single cell analysis 10th -11th March [...]
2805, 2014
Diatech Pharmacogenetics at the European at Human Genetics Conference, May 31st – June 3rd, 2014
Join us at the stand number 348 with Diatech LabLine and Nanostring Technologies. [...]
610, 2013
Diatech partecipates at the “Fifth International Symposium: Primary systemic treatment in the management of operable breast cancer”
From 5 to 7 October in Cremona (Trecchi Palace ) [...]
2908, 2013
Diatech Pharmacogenetics updates its kit for the analysis of KRAS and NRAS on the basis of the Amgen-AIFA information note
We are pleased to inform you that the kit Myriapod® [...]
2803, 2013
Diatech Pharmacogenetics and Horizon Diagnostics Reach Distribution Deal for Molecular Reference Standards
Two leading companies in the diagnosis united in the fight [...]
404, 2012
PPT Presentations Available – 3rd Annual Course of Pharmacogenetics and Personalized Medicine in Rome 9/10 February 2012
Please find below the PDF presentation discussed during the 3rd [...]